Trials / Terminated
TerminatedNCT06567002
A Study of MK-6552 and the Effect of Food in Healthy Participants (MK-6552-006)
A Study to Evaluate the Pharmacokinetics of Single Dose Formulations of MK-6552 and the Effect of Food in Healthy Study Participants
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to learn what happens to levels of MK-6552 in the blood when MK-6552 is given in different forms to healthy adult participants under fasted and fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-6552 | Oral Administration |
Timeline
- Start date
- 2024-09-09
- Primary completion
- 2024-11-15
- Completion
- 2024-11-15
- First posted
- 2024-08-22
- Last updated
- 2024-12-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06567002. Inclusion in this directory is not an endorsement.